Company · CIK 0000849146 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Lifevantage Corp · LFVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 PForm 4 → | Sep 17, 4:05 pm EDT | Darwin LewisDirector | 976 | $6.22 | $6,071 | 138,244 | +0.71% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 6:55 pm EDT | Kristen CunninghamChief Sales Officer | 9,001 | $6.18 | $55,649 | 120,162 | −6.97% | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:56 pm EDT | Carl AureChief Financial Officer | 1,869 | $6.37 | $11,906 | 156,495 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:55 pm EDT | Kristen CunninghamChief Sales Officer | 2,254 | $6.37 | $14,358 | 129,163 | — | |
| Aug 6, 2026 AForm 4 → | Aug 10, 5:19 pm EDT | Terrence MooreheadPresident and CEO, Director | 308,642 | — | — | 308,642 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 4:32 pm EDT | Carl AureChief Financial Officer | 1,361 | $6.25 | $8,506 | 155,554 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 4:32 pm EDT | Kristen CunninghamChief Sales Officer | 1,717 | $6.25 | $10,731 | 131,417 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 4:31 pm EDT | Alissa NeufeldGeneral Counsel | 1,342 | $6.25 | $8,388 | 112,744 | — | |
| Jun 15, 2026 PForm 4 → | Jun 17, 4:05 pm EDT | Darwin LewisDirector | 705 | $8.60 | $6,059 | 137,268 | +0.52% | 10b5-1 |
| Jun 3, 2026 SForm 4 → | Jun 5, 4:05 pm EDT | Michael A BeindorffDirector | 10,000 | $8.55 | $85,459 | 41,625 | −19.4% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 AForm 4 → | Aug 10, 5:19 pm EDT | Terrence MooreheadPresident and CEO, Director | 540,123 | — | — | 540,123 | — |